Retirement Guys Formula’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,984
Closed -$641K 166
2025
Q3
$641K Sell
1,984
-2,220
-53% -$690K 0.23% 109
2025
Q2
$1.64M Buy
4,204
+37
+0.9% +$14.9K 0.62% 58
2025
Q1
$1.81M Buy
4,167
+1,373
+49% +$551K 0.9% 29
2024
Q4
$1.03M Buy
2,794
+84
+3% +$35.2K 0.52% 59
2024
Q3
$1.41M Buy
2,710
+208
+8% +$111K 0.66% 50
2024
Q2
$1.36M Buy
2,502
+101
+4% +$53.4K 0.65% 46
2024
Q1
$1.25M Buy
2,401
+286
+14% +$142K 0.61% 55
2023
Q4
$997K Buy
2,115
+212
+11% +$98K 0.53% 56
2023
Q3
$829K Buy
+1,903
New +$863K 0.58% 51
2022
Q1
Sell
-637
Closed -$295K 140
2021
Q4
$295K Buy
+637
New +$268K 0.23% 82

Other funds holding ELV

Retirement Guys Formula's ELV Position: Q4 2025 in Review

Retirement Guys Formula sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,984 shares — an estimated $641K sold.

Retirement Guys Formula first reported a position in ELV in Q4 2021 and held it in 10 quarters. The position peaked at $1.81M in Q1 2025. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Retirement Guys Formula reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Retirement Guys Formula sold 1,984 Elevance Health shares in Q4 2025, an estimated $641K.
  • Retirement Guys Formula first reported a position in Elevance Health in Q4 2021 and held it in 10 quarters.
  • Retirement Guys Formula's Elevance Health position peaked at $1.81M in Q1 2025.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Retirement Guys Formula's 13F filing for Q4 2025, filed 23 Jan 2026.